Inovio Pharmaceuticals (INO) Asset Utilization Ratio (2011 - 2025)
Inovio Pharmaceuticals (INO) posted Asset Utilization Ratio of 0.0 for Q4 2025, down 65.68% sequentially from 0.0 in Q3 2025, and down 54.0% YoY from 0.0 in Q4 2024.
Inovio Pharmaceuticals (INO) Asset Utilization Ratio (2011 - 2025) Analysis & Trends
Inovio Pharmaceuticals has reported Asset Utilization Ratio for 15 years, with the latest figure at 0.0 in Q4 2025.
- Quarterly Asset Utilization Ratio fell 54.0% year-over-year to 0.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0 (down 54.0% YoY) and the FY2025 annual result came in at 0.0, down 54.53% from the prior year.
- Asset Utilization Ratio declined to 0.0 in Q4 2025 per INO's latest filing, from 0.0 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.04 in Q2 2023 and troughed at 0.0 in Q4 2025.
- A 5-year average of 0.01 and a median of 0.0 in 2023 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio soared 871.97% in 2023, then tumbled 88.31% in 2024.
- Over 5 years, Asset Utilization Ratio stood at 0.0 in 2021, then soared by 705.63% to 0.03 in 2022, then sank by 83.51% to 0.0 in 2023, then sank by 56.74% to 0.0 in 2024, then tumbled by 54.0% to 0.0 in 2025.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.0, 0.0, and 0.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.13 |
| 10 | Inovio Pharmaceuticals | 96.32 Mn | 96.32 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.04 |
| Mar 31, 2023 | 0.03 |
| Dec 31, 2022 | 0.03 |
| Sep 30, 2022 | 0.03 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.01 |
| Jun 30, 2021 | 0.01 |
| Mar 31, 2021 | 0.01 |